Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress. | Cancer Metab | 2022 | 35787728 | PubTator, text mining | PubMed |
| Research on the Mechanism of Asperosaponin VI for Treating Recurrent Spontaneous Abortion by Bioinformatics Analysis and Experimental Validation. | Evid Based Complement Alternat Med | 2022 | 35783512 | PubTator, text mining | PubMed |
| Mechanisms and Regulation of DNA-Protein Crosslink Repair During DNA Replication by SPRTN Protease. | Front Mol Biosci | 2022 | 35782873 | PubTator, text mining | PubMed |
| RecQ Helicase Somatic Alterations in Cancer. | Front Mol Biosci | 2022 | 35782872 | PubTator, text mining | PubMed |
| Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration. | Brain | 2022 | 35776111 | PubTator, text mining | PubMed |
| Regulation and dysregulation of hair regeneration: aiming for clinical application. | Cell Regen | 2022 | 35773427 | PubTator, text mining | PubMed |
| Computational exploration of maternal embryonic leucine zipper kinase (MELK) as a cancer drug target. | Saudi J Biol Sci | 2022 | 35769060 | PubTator, text mining | PubMed |
| Reconsidering the mechanisms of action of PARP inhibitors based on clinical outcomes. | Cancer Sci | 2022 | 35766436 | PubTator, text mining | PubMed |
| A novel irinotecan derivative ZBH-1207 with different anti-tumor mechanism from CPT-11 against colon cancer cells. | Mol Biol Rep | 2022 | 35764749 | PubTator, text mining | PubMed |
| Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes. | Front Genet | 2022 | 35754823 | PubTator, text mining | PubMed |
| The Development of FAK Inhibitors: A Five-Year Update. | Int J Mol Sci | 2022 | 35742823 | PubTator, text mining | PubMed |
| Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. | Cancers (Basel) | 2022 | 35740594 | PubTator, text mining | PubMed |
| Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2. | J Infect Public Health | 2022 | 35738053 | PubTator, text mining | PubMed |
| Single-Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death. | Anal Chem | 2022 | 35731985 | PubTator, text mining | PubMed |
| Design, synthesis and bioactivity evaluation of favorable evodiamine derivative scaffold for developing cancer therapy. | Eur J Med Chem | 2022 | 35728506 | PubTator, text mining | PubMed |
| Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy. | Cancer Manag Res | 2022 | 35720644 | PubTator, text mining | PubMed |
| Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer. | Thorac Cancer | 2022 | 35719112 | PubTator, text mining | PubMed |
| Hallmarks of DNA replication stress. | Mol Cell | 2022 | 35714587 | PubTator, text mining | PubMed |
| Signal pathways and precision therapy of small-cell lung cancer. | Signal Transduct Target Ther | 2022 | 35705538 | PubTator, text mining | PubMed |
| Interplay between symmetric arginine dimethylation and ubiquitylation regulates TDP1 proteostasis for the repair of topoisomerase I-DNA adducts. | Cell Rep | 2022 | 35705029 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=50